Education
About Us
Working with TipRanks
Follow Us
QuidelOrtho (QDEL)
NASDAQ:QDEL
QDEL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.05 - $49.45
Previous CloseN/A
Volume114.08K
Average Volume (3M)1.33M
Market Cap
$2.01B
Enterprise Value$4.60B
Total Cash (Recent Filing)$151.70M
Total Debt (Recent Filing)$2.79B
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Oct 29, 2025EPS Estimate
0.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding67,900,470
10 Day Avg. Volume1,470,341
30 Day Avg. Volume1,329,013
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.99
Price to Sales (P/S)1.06
P/FCF Ratio-26.38
Enterprise Value/Market Cap2.29
Enterprise Value/Revenue1.68
Enterprise Value/Gross Profit3.68
Enterprise Value/Ebitda20.64
Forecast
1Y Price Target
$39.57Price Target Upside42.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Cost ManagementThe company announced additional cost savings initiatives, which are expected to enhance financial performance.
EarningsQuidelOrtho’s second-quarter results met or exceeded expectations as full-year guidance for revenue and earnings were maintained.
Bears Say
Revenue DecreaseThere is a decrease in first-quarter revenue expectations primarily driven by a reduction in COVID and flu revenue.
Tariff ChallengesQuidelOrtho faces challenges due to tariff exposure, with a significant portion of revenue coming from China and being subject to U.S. tariffs.
QuidelOrtho News
QDEL FAQ
What was QuidelOrtho’s price range in the past 12 months?
QuidelOrtho lowest stock price was $22.05 and its highest was $49.45 in the past 12 months.
What is QuidelOrtho’s market cap?
QuidelOrtho’s market cap is $2.01B.
When is QuidelOrtho’s upcoming earnings report date?
QuidelOrtho’s upcoming earnings report date is Oct 29, 2025 which is in 20 days.
How were QuidelOrtho’s earnings last quarter?
QuidelOrtho released its earnings results on Aug 05, 2025. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.002 by $0.118.
Is QuidelOrtho overvalued?
According to Wall Street analysts QuidelOrtho’s price is currently Undervalued.
Does QuidelOrtho pay dividends?
QuidelOrtho does not currently pay dividends.
What is QuidelOrtho’s EPS estimate?
QuidelOrtho’s EPS estimate is 0.49.
How many shares outstanding does QuidelOrtho have?
QuidelOrtho has 67,900,470 shares outstanding.
What happened to QuidelOrtho’s price movement after its last earnings report?
QuidelOrtho reported an EPS of $0.12 in its last earnings report, beating expectations of $0.002. Following the earnings report the stock price went down -1.014%.
Which hedge fund is a major shareholder of QuidelOrtho?
Currently, no hedge funds are holding shares in QDEL
QuidelOrtho Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$39.57 (42.85% Upside)
$39.57 (42.85% Upside)
Blogger Sentiment
Bullish
QDEL Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.42%
12-Months-Change
Fundamentals
Return on Equity
-14.80%
Trailing 12-Months
Asset Growth
-4.64%
Trailing 12-Months
Company Description
QuidelOrtho
QuidelOrtho Corporation (QDEL) is a leading provider of diagnostic solutions, primarily focused on infectious diseases, reproductive health, and acute care testing. The company operates in the healthcare sector, specializing in the development, manufacturing, and marketing of rapid diagnostic tests and related technologies. QuidelOrtho's core products include point-of-care testing devices, molecular diagnostics, and immunoassays, which are designed to provide rapid and accurate results for healthcare professionals and patients.
QDEL Company Deck
QDEL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a balanced outlook for QuidelOrtho. While the company demonstrated strong growth in certain segments and regions, and improved profitability metrics, it also faced challenges such as a decline in North America revenue and decreased COVID-related revenue. The solid performance outside North America and improved profitability metrics are counterbalanced by the revenue declines in North America and COVID segments.View all QDEL earnings summariesQDEL Stock 12 Month Forecast
Average Price Target
$39.57
▲(42.85% Upside)
Technical Analysis
Ownership Overview
0.68% Insiders
38.64% Mutual Funds
1.67% Other Institutional Investors
27.90% Public Companies and
Individual Investors